WHWK
WHWK
NASDAQ · Biotechnology

Whitehawk Therapeutics Inc

$4.58
+0.17 (+3.85%)
As of Jun 30, 10:31 PM ET ·
Analyst Consensus
Buy
12
Analysts
Moderate
Coverage
Buy 8 67%
Hold 4 33%
Sell 0 0%
Price Target
Analyst Price Target +277.9% upside
Low Target $14.24
Average Target $17.31
High Target $28.90
Current Price $4.58
Current
$4.58
Target
$17.31
$14.24 $17.31 avg $28.90
Scenario Analysis
Bear Case
$14.24
210.9%
Low target
Base Case
$17.31
+277.9%
Avg target
Bull Case
$28.90
+531.0%
High target
Risk/Reward
2.5x
Favorable
Price in Context
52-Week High
$5.50
-16.7% from high
52-Week Low
$1.57
+191.7% from low
Target vs 52W High
$17.31
+215.0% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +2.4%
AMGN
Amgen Inc
Hold 44 50% $190.87 -47.3%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +187.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -11.8%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.7%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -66.0%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -39.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -47.4%